SVB Leerink reiterated coverage on Enanta Pharmaceuticals with a new price target

2/9/22 6:16:13 AM ET

Biotechnology: Pharmaceutical Preparations

Health Care

SVB Leerink reiterated coverage of Enanta Pharmaceuticals with a rating of Market Perform and set a new price target of $68.00 from $80.00 previously

Save time and jump to the most important pieces.

Recent Analyst Ratings for
$ENTA

Date	Price Target	Rating	Analyst
8/9/2023	$14.00	Neutral → Underweight	JP Morgan
8/8/2023	$49.00 → $18.00	Buy → Hold	Jefferies
12/9/2022	$56.00	Buy	H.C. Wainwright
7/6/2022	$62.00	In-line → Outperform	Evercore ISI
6/1/2022	$39.00	Underperform → In-line	Evercore ISI
2/9/2022	$80.00 → $68.00	Market Perform	SVB Leerink
1/13/2022	$85.00 → $80.00	Market Perform	SVB Leerink
11/24/2021	$55.00 → $73.00	Perform	Oppenheimer